neostigmine has been researched along with Malignant Melanoma in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becquart, O | 1 |
| Lacotte, J | 1 |
| Malissart, P | 1 |
| Nadal, J | 1 |
| Lesage, C | 1 |
| Guillot, B | 1 |
| Du Thanh, A | 1 |
| Dalal, FY | 1 |
| Bennett, EJ | 1 |
| Raj, PP | 1 |
| Lee, DG | 1 |
1 review available for neostigmine and Malignant Melanoma
| Article | Year |
|---|---|
Myasthenia Gravis Induced by Immune Checkpoint Inhibitors.
Topics: Aged; Antineoplastic Agents, Immunological; Female; Humans; Melanoma; Myasthenia Gravis; Neostigmine | 2019 |
1 other study available for neostigmine and Malignant Melanoma
| Article | Year |
|---|---|
Dystrophia myotonica: a multisystem disease.
Topics: Anesthesia; Atropine; Cholinesterases; Electromyography; Halothane; Humans; Male; Melanoma; Middle A | 1972 |